US GOV SEC HEALTH has a total of 11 patent applications. Its first patent ever was published in 1997. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are EPIAXIS THERAPEUTICS PTY LTD, DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS and CENTRAL ADELAIDE LOCAL HEALTH NETWORK INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Palmieri Diane | 4 |
#2 | Steeg Patricia | 4 |
#3 | Mueller Ken | 3 |
#4 | Ryba Nick | 3 |
#5 | Zuker Charles S | 3 |
#6 | Adler Jon Elliot | 2 |
#7 | Hoon Mark | 2 |
#8 | Abrams Scott | 1 |
#9 | Xu Qun | 1 |
#10 | Kleinman Joel E | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008106524A1 | Use of histone deacetylase inhibitors for the treatment of central nervous system metastases | |
AU2002254524A1 | Use of semenogelin in the diagnosis, prognosis and treatment of cancer | |
EP0895538A1 | Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes |